Literature DB >> 7932100

[Studies on the pharmacodynamics of ginsenoside-Rg1, -Rb1 and -Rb2 in rats].

Y Takino1.   

Abstract

The pharmacodynamics of ginsenoside-Rg1 (Rg1), -Rb1 (Rb1) and -Rb2 (Rb2) in rats were studied. In these studies, obvious differences were found in their pharmacodynamics. That is, Rg1 was easily hydrated to the same prospogenins in both rat stomach and 0.1 N HCl solution, but Rb1 and Rb2 were little decomposed (metabolised) in rat stomach and a small quantity of their hydroperoxide derivatives were found, but they were easily hydrated to their prosapogenins by 0.1 N HCl. These ginsenosides were decomposed (metabolised) to several prosapogenins by enteric bacteria and enteric enzymes. The modes of their decomposition (metabolism) were respectively different. In particular, the terminal sugar moiety at the C-20 hydroxy group was noted to affect the rates of their decomposition. The amount of Rg1 and Rb1 absorbed from the gastrointestinal tract of rat were 1.9% and 0.1% of the dose, respectively. And that of Rb2 was determined to be 3.7% of the dose by using 3H-labeled Rb2. Rg1 was excreted into the urine and bile in a 2:5 ratio. Rb1 and Rb2 were mainly excreted into the urine.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7932100

Source DB:  PubMed          Journal:  Yakugaku Zasshi        ISSN: 0031-6903            Impact factor:   0.302


  12 in total

1.  Database of traditional Chinese medicine and its application to studies of mechanism and to prescription validation.

Authors:  X Chen; H Zhou; Y B Liu; J F Wang; H Li; C Y Ung; L Y Han; Z W Cao; Y Z Chen
Journal:  Br J Pharmacol       Date:  2006-11-06       Impact factor: 8.739

2.  Pharmacology of ginsenosides: a literature review.

Authors:  Kar Wah Leung; Alice Sze-Tsai Wong
Journal:  Chin Med       Date:  2010-06-11       Impact factor: 5.455

3.  Biotransformation of ginsenosides Rb1, Rg3 and Rh2 in rat gastrointestinal tracts.

Authors:  Tianxiu Qian; Zongwei Cai
Journal:  Chin Med       Date:  2010-05-26       Impact factor: 5.455

4.  Bioconversion of ginsenosides in the american ginseng ( xī yáng shēn) extraction residue by fermentation with lingzhi ( líng zhī, ganoderma lucidum).

Authors:  Bo Yang Hsu; Chia Hui Chen; Ting Jang Lu; Lucy Sun Hwang
Journal:  J Tradit Complement Med       Date:  2013-04

5.  Six week swimming followed by acute uptakes of ginsenoside Rg1 may affect aerobic capacity of SD rats.

Authors:  Saebom Haam; Hyon Park
Journal:  J Exerc Nutrition Biochem       Date:  2015-12-31

Review 6.  A Role of Ginseng and Its Constituents in the Treatment of Central Nervous System Disorders.

Authors:  Natasya Trivena Rokot; Timothy Sean Kairupan; Kai-Chun Cheng; Joshua Runtuwene; Nova Hellen Kapantow; Marie Amitani; Akinori Morinaga; Haruka Amitani; Akihiro Asakawa; Akio Inui
Journal:  Evid Based Complement Alternat Med       Date:  2016-08-18       Impact factor: 2.629

Review 7.  A Preclinical Systematic Review of Ginsenoside-Rg1 in Experimental Parkinson's Disease.

Authors:  Liang Song; Meng-Bei Xu; Xiao-Li Zhou; Dao-Pei Zhang; Shu-Ling Zhang; Guo-Qing Zheng
Journal:  Oxid Med Cell Longev       Date:  2017-03-13       Impact factor: 6.543

Review 8.  Active ginseng components in cognitive impairment: Therapeutic potential and prospects for delivery and clinical study.

Authors:  Md Jakaria; Md Ezazul Haque; Joonsoo Kim; Duk-Yeon Cho; In-Su Kim; Dong-Kug Choi
Journal:  Oncotarget       Date:  2018-09-11

9.  Bioconversion of ginsenoside rb1 into compound k by Leuconostoc citreum LH1 isolated from kimchi.

Authors:  Lin-Hu Quan; Jin-Ying Piao; Jin-Woo Min; Dong-Uk Yang; Hee Nyeong Lee; Deok Chun Yang
Journal:  Braz J Microbiol       Date:  2011-09-01       Impact factor: 2.476

10.  New metabolites from the biotransformation of ginsenoside Rb1 by Paecilomyces bainier sp.229 and activities in inducing osteogenic differentiation by Wnt/β-catenin signaling activation.

Authors:  Wei Zhou; Hai Huang; Haiyan Zhu; Pei Zhou; Xunlong Shi
Journal:  J Ginseng Res       Date:  2017-03-22       Impact factor: 6.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.